obesity

A new drug is helping families who’ve spent years locking up or hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress is under threat.

Finding ways to shed a few pounds has become an American obsession. Now, researchers have hit on an idea that will be music to the ears of anyone trying.

Although the invasive Burmese pythons might be considered one of the state's most reviled reptiles, they have the potential to help with medical research. Stephen Hall tells us more on "The Florida Roundup."

Access remains limited to these effective but expensive drugs, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.

Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide (Wegovy), lost about 33 pounds.

Recent research from Drexel University explores a diet intervention specifically aimed at tackling the uniquely addictive nature of your standard gas station snack.

The drugmaker said it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver injury that ended once the person stopped the treatment.

Experts tend to focus on the kinds of foods you can eat to improve your health. But the speed at which you devour your dinner matters just as much.

Many employers and insurers are scaling back coverage and Medicare doesn’t cover the drugs for obesity. Meantime, some big employers are adding coverage, but their commitment isn’t guaranteed.

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.